m+Medelevator.RU
← Поиск публикаций
Renal failure · 2025

Long non-coding RNA NEAT1 mediated lupus nephritis induced podocytes pyroptosis through DNMT1-STING axis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zeng Yi, He Zhen-Kun, Liao Yun-Juan, Ma Ang, Li Cheng, Fu Ping

Аннотация

Lupus nephritis (LN), a severe complication of systemic lupus erythematosus, is characterized by podocyte injury mediated through autoantibody deposition, yet the underlying mechanisms remain incompletely understood. This study investigated the role of long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) in podocyte pyroptosis and its interaction with the stimulator of interferon genes (STING) pathway. Using peripheral blood mononuclear cells (PBMCs) and IgG isolated from 25 LN patients and 20 healthy controls, we found NEAT1 expression was significantly elevated in LN patient PBMCs and confirmed this in MRL/lpr mice. In vitro experiments demonstrated that LN-IgG treatment induced dose-dependent podocyte pyroptosis in human podocytes, an effect enhanced by NEAT1 overexpression and suppressed by its knockdown. Further analysis revealed STING expression correlated with NEAT1 levels, and STING knockdown attenuated pyroptosis. Mechanistically, we identified that NEAT1 bound directly to dysregulation of DNA methyltransferase 1 (DNMT1), with RNA immunoprecipitation (RIP)-qPCR showing a 4.3-fold enrichment (p < 0.001), and observed significant DNMT1 upregulation in LN. Functional studies demonstrated that DNMT1 overexpression counteracted NEAT1's regulatory effect on STING, establishing the NEAT1/DNMT1/STING signaling axis as a crucial regulator of podocyte pyroptosis in LN. These findings identify this novel signaling axis as a promising therapeutic target for antibody-mediated glomerular injury.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты